4/22 Taiwan Life Sciences Weekly Newsletter
2025-04-22 |
| Taiwan Life Sciences Weekly |
| BIO Asia-Taiwan 2025 to highlight new opportunities Press release 17 April, 2025 BIO Asia-Taiwan 2025 will be held from July 23 to 27, with this year's theme being "Next Wave of Biotech Opportunities". Building on last year's momentum, the event will once again feature three major forums: Innovation Forum, Investment Summit, and Regional Collaboration Forum. Over 900 companies have already signed up to exhibit across 2,200 booths, and the event is expected to attract biotech professionals from 50 countries, setting a new record in scale. More... (in Chinese) |
| Pulxion Medical Technology partners with medical device giant Medtronic to promote early disease screening 17 April, 2025 Pulxion Medical Technology has announced a strategic partnership with Medtronic through a Memorandum of Understanding (MOU). This collaboration will focus on promoting Pulxion Medical Technology's core products in Taiwan, Hong Kong, and Macau, aiming to accelerate the adoption of early disease screening technologies. Pulxion, a medical tech startup founded in 2020 is dedicated to developing innovative medical solutions particularly in the prevention and management of cardiovascular diseases. More... (in Chinese) |
| BIO Asia-Taiwan responds to evolving market conditions 17 April, 2025 A preview of BIO Asia-Taiwan was held on Wednesday, with organizers introducing topics to be addressed by the conference in late July, ranging from innovation to regional collaboration and tariffs. More... |
| TaiRx's cancer drug receives Orphan Drug status from US FDA, selenium injection expands into East Asian markets 17 April, 2025 TaiRx announced that the its new cancer drug was granted Orphan Drug status by the US FDA at the end of January, a move that is expected to attract investment and potential partners. And in order to expand the market for its selenium injection, TaiRx has partnered with local company Taiwan Biotech to target the Japanese and Southeast Asian markets. More... (in Chinese) |
| National Taiwan University Hospital claims world's first 'beating heart' transplant 16 April, 2025 National Taiwan University Hospital said Wednesday that its medical team completed a heart transplant surgery that kept the donor heart beating during the transplantation process. The hospital held a press conference on Wednesday to provide details about the surgery, claiming it to be the world's first of its kind. It said the procedure was also featured in the Journal of Thoracic and Cardiovascular Surgery Techniques, per CNA. More... |
| Foxconn Medical Bots at Nvidia GTC Heralds the Dawn of Smart Healthcare 15 April, 2025 During Nvidia's annual GTC extravaganza in March, Foxconn (Hon Hai Technology Group) not only showed off its rack-level server solutions based on Nvidia's latest computing platforms, it also demonstrated for the first time its "Nurabot," a medical assistant robot jointly developed with Taichung Veterans General Hospital (TCVGH). More... |
| JelloX Biotech Establishes US Research Base Press release 14 April, 2025 JelloX Biotech Inc., a Taiwan-based startup at the forefront of cancer pathology, is announcing it will open a lab in the Discovery Oasis biotechnology space in Phoenix, Arizona. An expansive 120-acre development, Discovery Oasis is envisioned as a biotechnology corridor of collaboration to advance groundbreaking solutions to humanity's most complex medical challenges. With around 1,100 square feet of space housing some of its most advanced equipment, JelloX will leverage its new lab for applying cutting-edge technologies like 3D imaging and AI to cancer pathology. More... |
| United Orthopedic deepens its presence in the North American market 13 April, 2025 United Orthopedic (TW: 4129) announced that several of its products are expected to receive approval from the US FDA and be launched this year, including the Modular Revision Hip and Press-Fit Patellar Knee implants. The company plans to continue introducing innovative products in the US as it deepens its presence in the North American market. In response to the challenge of tariffs from the US, United Orthopedic emphasized that the US is the world’s largest market for orthopedic joint implants, and market development efforts in the US have begun to bear fruit, with double-digit revenue growth in recent years and its revenue share from the US steadily increasing. More... (in Chinese) |
| ========================================= |
| Taiwan Bio Industry Organization (Taiwan BIO) Contact: Daisy Tsai Tel: +886 2 27836028 ext 14 FAX : +886 2 27836027 Mobile: +886 933-139647 | Line ID : daisy222 Email: daisy@taiwanbio.org.tw BIO Asia-Taiwan 2025 (23-27 July, 2025) ========================================= Taiwan Bio Industry Organization (TBIO) Room C229, Bldg. C, No.99, Ln. 130, Sec. 1, Academia Rd., Nangang Dist., Taipei, Taiwan (11571) ========================================= |